Stem Cell Transplant Advances and Use in the Age of Immunotherapy

Name: Stem Cell Transplant Advances and Use in the Age of Immunotherapy
Start: 2023-09-20T10:00:00-05:00
End: 2023-09-20T11:00:00-05:00

Stem Cell Transplant Advances and Use in the Age of Immunotherapy

Podcast

Sep 20, 2023 / 10:00AM CDT

Listen to Podcast

Event Description

TO JOIN THE SHOW BY PHONE, PLEASE CALL 347-637-2631.

Dr. John DiPersio of Washington University shares how stem cell transplant is evolving for multiple myeloma care. As a decades old but tried and true and effective therapy, it is still routinely used in the myeloma clinic as a way to typically provide an extended remission. Advances are being made in the stem cell transplant process which include a recent FDA approval of a stem cell collection drug called motixafortide (Aphexda) that can speed the time and quality of collected stem cells. Dr. DiPersio will also share how many patients may want to undergo stem cell collection whether they plan to do a stem cell transplant or not and how transplant use is changing in the age of immunotherapies.

Thanks to our episode sponsor, GSK.

We appreciate your donations to support the HealthTree Podcast for Multiple Myeloma.

DONATE

Schedule & Agenda

10:00 AM

Welcome

Jennifer Ahlstrom

Welcome, Announcements & Introduction

10:00 AM

Welcome

Jennifer Ahlstrom

Welcome, Announcements & Introduction

10:05 AM

Discussion with Dr. DiPersiio

John DiPersio, MD, PhD

A discussion of stem cell transplant with Dr. DiPersio.

10:05 AM

Discussion with Dr. DiPersiio

John DiPersio, MD, PhD

A discussion of stem cell transplant with Dr. DiPersio.

10:50 AM

Q&A

Audience is able to call in to the radio show. Call 347-637-2631 and press 1 on your keypad to ask Dr. DiPersio questions about what was discussed during our interview today.

10:50 AM

Q&A

Audience is able to call in to the radio show. Call 347-637-2631 and press 1 on your keypad to ask Dr. DiPersio questions about what was discussed during our interview today.

Speakers & Moderators

Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

John DiPersio, MD, PhD

St. Louis, MO

John F. DiPersio, MD, PhD is Director of the Center for Gene and Cellular Immunotherapy at the Siteman Cancer Institute at Washington University. He is the Virginia E. and Sam J. Golman Professor in Medicine in the Division of Oncology, Bone Marrow Transplantation & Leukemia, Stem Cell Biology, Department of Pediatrics and Department of Pathology & Immunology. His research interests include both auto and allo stem cell transplant, growth factor receptors, graft-versus-host disease and leukemia genomics.

Read Bio